Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study.

Dana BliucT TranT van GeelJ D AdachiC BergerJ van den BerghJ A EismanP GeusensD GoltzmanD A HanleyR G JosseS KaiserC S KovacsL LangsetmoJ C PriorT V NguyenJ R Centernull null

Published in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2019)

Compared to no treatment, nitrogen but not non-nitrogen bisphosphonates appear to be associated with better survival.

Keyphrases

combination therapy
replacement therapy